Srivats Madhavan, MBBS

Srivats Madhavan practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Srivats Madhavan's NPI, 1265721021, was assigned on April 1, 2011. Srivats Madhavan holds Wisconsin license 70278.

Srivats Madhavan's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Srivats Madhavan's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. Srivats Madhavan is also affiliated with Froedtert Menomonee Falls Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Srivats Madhavan to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Srivats Madhavan practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Srivats Madhavan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Srivats Madhavan's licenses on file in 3 states: Wisconsin, California and Ohio.

CMS data shows 86 Medicare services from Srivats Madhavan across 5 procedure codes in 2024, for 92 Medicare patients. Medicare paid $8,271 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 92 Medicare patients who saw Srivats Madhavan in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Srivats Madhavan's median patient age at 66, with 56% women.

In 2024, Srivats Madhavan wrote 104 Medicare Part D claims for 66 patients. 82% of them were for generic drugs. CMS names the drug for 46 of them, across 2 drugs with 11 or more claims each, at $808 in total drug cost. In 2023, CMS named 51 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Srivats Madhavan for performance year 2024, reported as part of a group. Srivats Madhavan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 77 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Srivats Madhavan, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Srivats Madhavan, published from 2011 to 2025. 2011 was the busiest year, with 3. The most frequent topics are Pancreatic Neoplasms and Adenocarcinoma. Srivats Madhavan's most frequent co-authors are Kulwinder S. Dua, MD, Douglas B. Evans, MD and Ben George, MD.

CMS Open Payments shows 63 general payments to Srivats Madhavan from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 84% of the total. Olympus Corporation of the Americas paid the most, $3,209.